An adolescent or young adult’s first exposure to opioids often occurs following a third molar extraction, and even though85%-90%of these patients find the experience unpleasant due to side effects, up to 15% are at risk for misuse, abuse, and addiction. To mitigate risk of opioid dependency it is imperative that dentists and oral surgeons are […]

It has long been a habit of dentists and oral and maxillofacial surgeons to prescribe narcotics following surgeries such as third molar extraction, with many prescribing as many as 20-30 tablets. A recent study of 105 patients who underwent third molar extraction saw 8 surgeons prescribing 1,773 opioid units, with only 38.4% of those units […]

Crohn’s disease (CD), an inflammatory bowel disease (IBD) that affects at least 780,000 people in the United States, has recently seen its management goals evolve from merely controlling flares to achieving and sustaining deep remission, which can help a patient avoid progressive bowel wall damage. The only treatments effective in achieving durable deep remission are […]

The management of ulcerative colitis (UC) is evolving. In the last 2years, the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG)released updated, evidence-based treatment guidelines with recommendations for disease stratification, prognosis, treatment options, and disease monitoring. Additionally, new efficacy, safety, and comparative effectiveness data from advanced treatment options are now available, and […]

@MondayNightIBD brings social media and clinical practice influencers in gastroenterology together in a weekly online conversation that has become an international platform, moving the field of gastroenterology forward. It crowdsources the knowledge and experience of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients to meet the many challenges of IBD. In this live […]

Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In […]

Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In order to achieve reduced EDS, cataplexy and sleep paralysis/hypnagogic hallucinations must be controlled to improve disturbed nighttime sleep, which then improves fatigue and brain fog and reduces psychosocial dysfunction, therefore improving quality of life (QoL). […]

Screening for hepatitis B virus (HBV) in the emergency department (ED) is an important public health opportunity, as it can reduce transmission in high-risk patients and facilitate linkage to care. HBV testing can be included when screening for sexually transmitted infections(STIs)and hepatis C virus (HCV), and emergency department (ED) physicians to employ strategies for follow-up, […]

An estimated 1 million people get shingles each year, with about 1 in 10 developing postherpetic neuralgia that lasts months or years, and 1% -4% being hospitalized for complications. Despite the availability of a shingles vaccine, about only 1 in 3 eligible adults ≥ 60 years old and just 37% of adults ≥ 65 years […]

The approval of ocrelizumab for primary progressive multiple sclerosis (PPMS) was groundbreaking, and more recently the MS community bore witness to another major breakthrough in MS management when siponimod was approved for secondary progressive MS (SPMS). Additionally, new investigational agents such as MD1003 (high-dose biotin) and masitinib are also being evaluated for treatment of PPMS, […]